NUTX vs HCSG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NUTX · Nutex Health$162.64 ▲ 0.33%
HCSG · Healthcare Services Group$24.72 ▼ 0.20%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NUTX +18.5%
- HCSG +32.9%
Head to head
| Metric | NUTX | HCSG |
|---|---|---|
| Price | $162.64 | $24.72 |
| Change today | ▲ 0.33% | ▼ 0.20% |
| Market cap | $1.12B | $1.67B |
| Return, 3 months | -13.3% | +8.4% |
| Return, year to date | -1.2% | +29.3% |
| Return, 1 year | +18.8% | +37.6% |
| P/E (TTM) | 7.0 | 16.7 |
| P/B | 2.6 | 3.1 |
| P/E percentile vs own 5y | 65th | 9th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -18.7% | +3.3% |
| Net profit growth (YoY) | -40.8% | -42.1% |
| Gross margin | 47.8% | 16.1% |
| Operating margin | 39.0% | 6.3% |
| Net margin | 20.7% | 5.6% |
| Return on equity | 43.8% | 20.4% |
| Analyst target vs. price | +94.5% | +2.5% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 37 | 55 |
| 30-day volatility | 77.2% | 50.6% |
| Max drawdown, 1 year | -54.3% | -19.9% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HCSG is the largest of the group by market value.
- HCSG has returned the most over the past year.
- NUTX carries the lowest trailing P/E.
- HCSG is growing revenue fastest.
- NUTX keeps the most profit per dollar of sales.
- HCSG has been the calmest stock over the last 30 days.